Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 25, Issue 6, Pages 1026-1035
Publisher
Springer Nature
Online
2011-04-06
DOI
10.1038/leu.2011.53
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells
- (2010) Yijiang Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
- (2010) N C Gutiérrez et al. LEUKEMIA
- Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model
- (2010) Jason T. Yustein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A monoclonal gammopathy precedes multiple myeloma in most patients
- (2009) B. M. Weiss et al. BLOOD
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- The IKK2/NF- B pathway suppresses MYC-induced lymphomagenesis
- (2009) K. Klapproth et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case
- (2009) L. Chiecchio et al. HAEMATOLOGICA
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor
- (2008) W.-L. Zhao et al. BLOOD
- AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies
- (2008) Marta Chesi et al. CANCER CELL
- IL-6-Induced Stimulation of c-Myc Translation in Multiple Myeloma Cells Is Mediated by Myc Internal Ribosome Entry Site Function and the RNA-Binding Protein, hnRNP A1
- (2008) Y. Shi et al. CANCER RESEARCH
- Clinical and biological significance of RAS mutations in multiple myeloma
- (2008) W J Chng et al. LEUKEMIA
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- IRF4 addiction in multiple myeloma
- (2008) Arthur L. Shaffer et al. NATURE
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More